ViroGates A/S VIRO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- DKK 6.84
- Day Range
- DKK 6.84–6.84
- 52-Week Range
- DKK 4.98–19.51
- Bid/Ask
- DKK 6.84 / DKK 7.12
- Market Cap
- DKK 44.08 Mil
- Volume/Avg
- 6 / 11,211
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.58
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.virogates.com
Valuation
Metric
|
VIRO
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.59 |
Price/Sales | 3.58 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
VIRO
|
---|---|
Quick Ratio | 8.56 |
Current Ratio | 10.84 |
Interest Coverage | −22.08 |
Quick Ratio
VIRO
Profitability
Metric
|
VIRO
|
---|---|
Return on Assets (Normalized) | −69.79% |
Return on Equity (Normalized) | −96.02% |
Return on Invested Capital (Normalized) | −73.59% |
Return on Assets
VIRO
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Znvcrdvf | Gmhzj | $184.7 Bil | |
SYK
| Stryker Corp | Xqkbygdlwn | Bkcmc | $126.5 Bil | |
MDT
| Medtronic PLC | Vttwnrhtz | Jgsdvp | $108.7 Bil | |
BSX
| Boston Scientific Corp | Sjjhmytbp | Vnkhc | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Ttdggxvvrp | Dfdvh | $51.7 Bil | |
DXCM
| DexCom Inc | Ltxwhxrcwj | Pflm | $51.5 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Yyytjdqvd | Zfzx | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Dwwkkznm | Qlznlsh | $24.2 Bil | |
ALGN
| Align Technology Inc | Lzbnksxg | Pzplmd | $21.6 Bil | |
PODD
| Insulet Corp | Czhfdnmwx | Qxpxvkz | $12.9 Bil |